Literature DB >> 10220692

Prognostic models of thirty-day mortality and morbidity after major pulmonary resection.

D H Harpole1, M M DeCamp, J Daley, K Hur, C A Oprian, W G Henderson, S F Khuri.   

Abstract

BACKGROUND: A part of the prospective, multi-institutional National Veterans Affairs Surgical Quality Improvement Program was developed to predict 30-day mortality and morbidity for patients undergoing a major pulmonary resection.
METHODS: Perioperative data were acquired from 194,319 noncardiac surgical operations at 123 Veterans Affairs Medical Centers between October 1, 1991, and August 31, 1995. Current Procedural Terminology code-based analysis was undertaken for major pulmonary resections (lobectomy and pneumonectomy). Preoperative, intraoperative, and outcome variables were collected. The 30-day mortality and morbidity models were developed by means of multivariable stepwise logistic regression with the preoperative and intraoperative variables used as independent predictors of outcome.
RESULTS: A total of 3516 patients (mean age 64 9 years) underwent either lobectomy (n = 2949) or pneumonectomy (n = 567). Thirty-day mortality was 4.0% for lobectomy (119/2949) and 11.5% for pneumonectomy (65/567). The preoperative predictors of 30-day mortality were albumin, do not resuscitate status, transfusion of more than 4 units, age, disseminated cancer, impaired sensorium, prothrombin time more than 12 seconds, type of operation, and dyspnea. When the intraoperative variables were considered, intraoperative blood loss was added to the preoperative model. In the presence of these intraoperative variables in the model, do not resuscitate status and prothrombin time more than 12 seconds were only marginally significant. Thirty-day morbidity, defined as the presence of 1 or more of the 21 predefined complications, was 23.8% for lobectomy (703/2949) and 25.7% for pneumonectomy (146/567). In multivariable models, independent preoperative predictors (P <.05) of 30-day morbidity were age, weight loss greater than 10% in the 6 months before surgery, history of chronic obstructive pulmonary disease, transfusion of more than 4 units, albumin, hemiplegia, smoking, and dyspnea. When intraoperative variables were added to the preoperative model, the duration of operation time and intraoperative transfusions were included in the model and albumin became marginally significant.
CONCLUSIONS: This analysis identifies independent patient risk factors that are associated with 30-day mortality and morbidity for patients undergoing a major pulmonary resection. This series provides an initial risk-adjustment model for major pulmonary resections. Future refinements will allow comparative assessment of surgical outcomes and quality of care at many institutions.

Entities:  

Mesh:

Year:  1999        PMID: 10220692     DOI: 10.1016/S0022-5223(99)70378-8

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  54 in total

1.  A model for morbidity after lung resection in octogenarians.

Authors:  Mark F Berry; Mark W Onaitis; Betty C Tong; David H Harpole; Thomas A D'Amico
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-26       Impact factor: 4.191

2.  Cross-industry standard process for data mining is applicable to the lung cancer surgery domain, improving decision making as well as knowledge and quality management.

Authors:  Eduardo Rivo; Javier de la Fuente; Ángel Rivo; Eva García-Fontán; Miguel-Ángel Cañizares; Pedro Gil
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

Review 3.  Postlobectomy Early Complications.

Authors:  Elena Ziarnik; Eric L Grogan
Journal:  Thorac Surg Clin       Date:  2015-06-12       Impact factor: 1.750

4.  The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation.

Authors:  Amr Badawy; Toshimi Kaido; Ahmed Hammad; Shintaro Yagi; Naoko Kamo; Atsushi Yoshizawa; Hideaki Okajima; Shinji Uemoto
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

5.  Changes in the Surgical Treatment Strategies for Nonsmall Cell Lung Cancer in the Past 20 Years: A Single-Center Experience.

Authors:  Ahmet Üçvet; Soner Gürsoy; Serkan Yazgan
Journal:  Turk Thorac J       Date:  2020-01-01

6.  Expired gas analysis during exercise testing pre-pneumonectomy.

Authors:  Yoshinori Nagamatsu; Yasuhiro Terazaki; Fumihiko Muta; Hideaki Yamana; Kazuo Shirouzu; Tatsuya Ishitake
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude.

Authors:  Trond-Eirik Strand; Hans Rostad; Ronald A M Damhuis; Jarle Norstein
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

Review 8.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

9.  Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management.

Authors:  Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  J Am Coll Surg       Date:  2013-12-12       Impact factor: 6.113

10.  Retrospective investigation of pulmonary resection in patients with high total pulmonary vascular resistance during preoperative unilateral pulmonary artery occlusion.

Authors:  Yoshinori Nagamatsu; Akira Ohkita; Norman Y Kimura; Goichi Nakayama; Ryozou Hayashida; Hideaki Yamana; Kazuo Shirouzu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.